Skip to main content
. Author manuscript; available in PMC: 2007 May 31.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1128–1132. doi: 10.1167/iovs.06-0999

Table 2.

Distribution of LOC387715-G/T among Cases and Controls from the AREDS and NEI Protocols

Geograpihic Atrophy
Choroidal Neovascularization
Combined
Genotypes Control Case P OR (95%CI) vs. GG P OR (95%CI) vs. GG P OR (95%CI) vs. GG
GG 217 (66.0%) 148 (37.1%) Reference 1 Reference 1 Reference 1
GT 100 (30.4%) 182 (45.6%) 3.40 × 10−7 2.87 (1.91–4.30) 2.29 × 10−6 2.48(1.70–3.61) 1.42 × 10−9 2.61 (1.89–3.61)
TT 12 (3.65%) 69 (17.3%) 1.73 × 10−6 6.43 (3.00–13.79) 2.39 × 10−11 10.12(5.12–20.01) 3.56 × 10−13 8.59 (4.49–16.46)
GT+TT 112(34.0%) 251 (69.2%) 2.07 × 10−8 3.24 (2.20–4.78) 2.92 × 10−10 3.0 (2.32–4.70) 9.06 × 10−15 3.25 (2.39–4.41)
G 534 (81.2%) 478 (59.9%) Reference 1 Reference 1 Reference 1
T 124 (18.8%) 320 (40.1%) 3.97 × 10−11 2.64 (1.97–3.54) 5.46 × 10−17 3.10(2.37–4.06) 1.80 × 10−18 2.88 (2.26–3.67)